What Is a PET Scan for Cancer and What to Expect

A PET scan is an imaging test that detects cancer by revealing which cells in your body are using unusually high amounts of energy. Cancer cells consume far more glucose (sugar) than normal cells, and a PET scan exploits this difference to make tumors visible. The test is used to find cancer, determine how far it has spread, check whether treatment is working, and spot cancer that comes back after treatment.

How a PET Scan Finds Cancer

Before the scan, you receive an injection of a radioactive tracer that mimics glucose. Because cancer cells have a high rate of glucose metabolism, they absorb significantly more of this tracer than healthy tissue does. When you lie inside the scanner, a ring of detectors picks up the tiny bursts of energy released by the tracer. The result is an image where cancer cells show up brighter than surrounding tissue, making even small clusters of abnormal activity visible.

Nearly all PET scans today are paired with a CT scan in a single machine called a PET/CT. The PET component shows metabolic activity (where cells are burning energy), while the CT provides a detailed anatomical map. Combining both lets doctors pinpoint exactly where in your body that bright spot is located, whether it’s inside a lymph node, a lung, or a bone. A newer alternative, PET/MRI, offers better contrast for soft tissues like the brain, liver, and pelvis, which can help characterize very small lesions.

What Doctors Use It For

PET scans serve four main roles in cancer care:

  • Diagnosis: When other imaging is inconclusive, a PET scan can help determine whether a suspicious mass is likely cancerous, sometimes sparing you a biopsy or helping doctors choose the best spot to biopsy.
  • Staging: After a cancer diagnosis, a PET/CT can reveal whether the cancer has spread to lymph nodes or distant organs. This is often the most common reason the scan is ordered, since staging determines the treatment plan.
  • Monitoring treatment: If tumors are responding to chemotherapy or radiation, their glucose uptake drops. A mid-treatment PET scan can show whether the current approach is working or needs to change.
  • Detecting recurrence: After treatment ends, PET scans can pick up cancer that returns, often before it would show on a standard CT or MRI alone.

What to Expect During the Procedure

The entire visit typically takes about two hours, though the scan itself is only around 30 minutes. After you check in, a technologist places a small IV line and injects the tracer. Then you wait quietly for about 60 minutes while the tracer circulates and gets absorbed by your cells. During this time you’ll be asked to sit or lie still, avoid talking, and not use your phone, because muscle activity can pull in the tracer and interfere with the images.

The scan itself feels similar to a CT. You lie on a narrow table that slides slowly through a large, open ring. You won’t feel any sensation from the scanner. Most people describe the experience as boring rather than uncomfortable. Once it’s over, you can eat, drink, and resume normal activities. The small amount of radioactive tracer leaves your body naturally through urine over the next several hours.

How to Prepare

Preparation matters more for a PET scan than for most imaging tests, because anything that affects your blood sugar can throw off the results. You’ll need to fast for at least six hours beforehand. During that time, only plain, unflavored water is allowed. No gum, candy, breath mints, or anything containing sugar or carbohydrates.

You should also avoid strenuous physical activity for at least 24 hours before the scan (48 hours is ideal). That includes jogging, cycling, weightlifting, heavy housework, and yard work. Even chewing gum the day before can light up jaw muscles on the scan and create confusing images. If you have diabetes, your care team will want your blood sugar at or below 200 mg/dL on the day of the scan. If it’s higher, the appointment will likely be rescheduled, since elevated blood sugar competes with the tracer and reduces the scan’s accuracy.

Accuracy and False Positives

PET scans are highly sensitive, meaning they’re good at catching cancer that’s present. But the tracer isn’t cancer-specific. Any cell that’s metabolically active will absorb it, including cells involved in infection, inflammation, or healing after surgery. The reported false positive rate for PET/CT is about 13%, largely driven by inflammatory cells at sites of infection or chronic conditions like sarcoidosis.

This is why a bright spot on a PET scan doesn’t automatically mean cancer. Doctors interpret PET results alongside your medical history, blood work, and other imaging. In many cases, a biopsy is still needed to confirm a diagnosis. The flip side, false negatives, can happen with very small tumors or slow-growing cancers that don’t consume much glucose.

Specialized Tracers Beyond Standard PET

The standard tracer works well for most solid tumors, but newer tracers are designed to target specific cancer types. The most notable is the PSMA PET scan for prostate cancer. PSMA is a protein found on the surface of prostate cancer cells. The tracer binds directly to this protein rather than relying on glucose uptake, making it far more precise for finding prostate cancer that has spread or returned after treatment.

A PSMA PET scan also plays a role in treatment planning. If the scan shows the tracer building up on prostate cancer cells, it signals that a targeted radioactive therapy aimed at PSMA may be effective. If the tracer doesn’t accumulate, that particular therapy is unlikely to help. While PSMA PET occasionally detects other cancers like lymphoma or lung cancer, this is rare, and the scan is primarily a prostate cancer tool.

Radiation Exposure

A whole-body PET/CT delivers about 25 millisieverts (mSv) of radiation. For context, the average American absorbs roughly 3 mSv per year from natural background sources like radon and cosmic rays. So a single PET/CT is equivalent to about eight years of everyday background exposure. That sounds like a lot, but for someone being evaluated for cancer, the diagnostic benefit almost always outweighs this risk. The radiation is not cumulative in the way many people fear: your body repairs most DNA damage from low-dose exposure over time.

Insurance and Coverage

Medicare covers PET scans for cancer when the results would change how the cancer is managed. That includes situations where staging remains unclear after standard imaging, when the scan might replace other tests that aren’t providing enough information, or when checking for recurrence after treatment. Coverage is not unlimited. For colorectal cancer, for instance, Medicare generally won’t cover whole-body PET scans more than once every 12 months unless there’s documented medical need. For lung nodules being monitored with PET, a repeat scan won’t be covered within 90 days of a negative result. Private insurers typically follow similar guidelines, often requiring prior authorization that your oncology team handles.